Progress and new techniques of MRI in diagnosis of prostate cancer

TONG Zi-bin; LIU Ai-lian

Journal of China Clinic Medical Imaging ›› 2016, Vol. 27 ›› Issue (3) : 207-211.

Author information +

History +

Abstract

MRI is an effective method in diagnosis of prostate cancer. In recent years, the function imaging techniques such as MRS, MR DWI, intravoxel incoherent motion diffusion weighted imaging(IVIM-DWI), MR diffusion tensor imaging(MR DTI), MR diffusion kurtosis imaging(MR DKI), MR SWI provides a great help in diagnosis of prostate cancer. This article is to review the progress of these new techniques in diagnosis of prostate cancer.

Key words

Prostatic neoplasms / Magnetic resonance imaging

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

TONG Zi-bin, LIU Ai-lian. Progress and new techniques of MRI in diagnosis of prostate cancer[J]. Journal of China Clinic Medical Imaging. 2016, 27(3): 207-211

References

[1]Siegel R, Ma J, Zou ZH, et al. Cancer statistics[J]. CA Cancer J Clin, 2014, 64(1): 9-29.
[2]韩苏军，张思维，陈万青，等. 中国前列腺癌发病现状和流行趋势分析[J]. 临床肿瘤学杂志，2013，18（4）：330-334.
[3]Nix JW, Turkbey B, Hoang A, et al. Very distal apical prostate tumors: identification on multiparametric MRI at 3 Tesla[J]. BJU Int, 2012, 110(11): 694-700.
[4]郭启勇. 实用放射学[M]. 3版. 北京：人民卫生出版社，2007：1025－1026.
[5]Rosenkrantz AB, Sabach A, Babb JS, et al. Prostate cancer: comparison of dynamic contrast-enhanced MRI techniques for localization of peripheral zone tumor[J]. AJR, 2013, 201(3): 471-478.
[6]Ren J, Huan Y, Wang H, et al. Dynamic contrast-enhanced MRI of benign prostatic hyperplasia and prostatic carcinoma: correlation with angiogenesis[J]. Clin Radiol, 2008, 63(2): 153-159.
[7]张莹，苗华栋，张长萃. 前列腺癌3T MR表观扩散系数与动态增强半定量参数的相关性研究[J]. 临床放射学杂志，2013，32（2）：210-214.
[8]李春媚，陈敏，李飒英，等. 3.0T磁共振扩散张量成像诊断前列腺外周带癌的初步研究[J]. 临床放射学杂志，2012，31（3）：398-401.
[9]Schlemmer HP, Merkle J, Grobholz R, et al. Can pre-operative contrast-enhanced dynamic MR imaging for prostate cancer predict microvessel density in prostatectomy specimens?[J]. Eur Radiol, 2004, 14(2): 309-317.
[10]Langer DL, vander Kwast TH, Evans AJ, et al. Prostate cancer detection with multi-parametric MRI: logistic regression analysis of quantitative T2, diffusion-weighted imaging, and dynamic contrast-enhanced MRI[J]. J Magn Reson Imaging, 2009, 30(2): 327-334.
[11]Chen YJ, Chu WC, Pu YS, et al. Washout gradient in dynamic contrast-enhanced MRI is associated with tumor aggressiveness of prostate cancer[J]. J Magn Reson Imaging, 2012, 36(4): 912-919.
[12]刘会佳，赵娓娓，任芳，等. 3.0T动态增强磁共振对前列腺癌的定量分析研究[J]. 放射学实践，2014，29（5）：477-481.
[13]Kurhanewiez J, Vjgneron DB, Hricak H, et al. Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high(0.24~0.7 cm3) spatial resolution[J]. Radiology, 1996, 198(3): 795-805．
[14]Costello LC, Frankin RB, Narayan P. Citrate in the diagnosis of prostate cancer[J]. Prostate, 1999, 38(3): 237-245.
[15]Kurhanewicz J, Vigneron DB, Nelson SJ, et al. Citrate as an in vivo marker to discriminate prostate cancer from benign prostatic hyperplasia and normal prostate peripheral zone: detection via localized proton spectroscopy[J]. Urology, 1995, 45(3): 459-466.
[16]Scheenen TW, Fütterer J, Weiland E, et al. Discriminating cancer from noncancer tissue in the prostate by 3-dimensional proton magnetic resonance spectroscopic imaging: a prospective multicenter validation study[J]. Invest Radiol, 2011, 46(1): 25-33.
[17]王霄英，周良平，丁建平，等. MRS对中国人前列腺癌鉴别诊断标准的初步研究[J]. 中国医学影像技术，2004，20（8）：1150-1153.
[18]Li B, Cai W, Lv D, et al． Comparison of MRS and DWI in the diagnosis of prostate cancer based on sextant analysis[J]. J Magn Reson Imaging, 2013, 37(1): 194-200．
[19]Yamamura J, Salomon G, Buchert R, et al． MR imaging of prostate cancer: diffusion weighted imaging and (3D) hydrogen 1H-MR spectroscopy in comparison with histology[J]. Radiol Res Pract, 2011, 2011: 616852．
[20]周红俐，赵建农，郭大静，等. 扩散张量成像联合3D-1H-MRS对前列腺癌诊断效能的研究[J]. 第三军医大学学报，2014，36（1）：63-67.
[21]王希明，白人驹，赵新，等. 扩散加权成像鉴别前列腺癌及良性前列腺增生的价值[J]. 中华放射学杂志，2006，40（7）：690-694.
[22]Mazzoni LN, Lucarini S, Chiti S, et al. Diffusion-weighted signal models in healthy and cancerous peripheral prostate tissues: comparison of outcomes obtained at different b-values[J]. J Magn Reson Imaging, 2014, 39(3): 512-518.
[23]Jie C, Rongbo L, Ping T. The value of diffusion-weighted imaging in the detection of prostate cancer: a meta-analysis[J]. Eur Radiol, 2014, 24(8): 1929-1941.
[24]Lawrence EM, Gallagher FA, Barrett T, et al. Preoperative 3-T diffusion-weighted MRI for the qualitative and quantitative assessment of extracapsular extension in patients with intermediate or high-risk prostate cancer[J]. AJR, 2014, 203(3): 280-286.
[25]Rud E, Baco E, Lien D, et al. Detection of radiorecurrent prostate cancer using diffusion-weighted imaging and targeted biopsies[J]. AJR, 2014, 202(3): 241-246.
[26]Wetter A, Nensa F, Lipponer C, et al. High and ultra-high b-value diffusion-weighted imaging in prostate cancer: a quantitative analysis[J]. Acta Radiol, 2015, 56(8): 1009-1015.
[27]Wang X, Qian Y, Liu B, et al. High-b-value diffusion-weighted MRI for the detection of prostate cancer at 3T[J]. Clin Radiol, 2014, 69(11): 1165-1170.
[28]Le Bihan D, Mangin JF, Poupon C, et al. Diffusion tensor imaging: concepts and applications[J]. J Magn Reson Imaging, 2001, 13(4): 534-546.
[29]王微微，刘爱连. 扩散张量成像在腹部的应用[J]. 国际医学放射学杂志，2011，34（3）：257-260.
[30]Li C, Chen M, Li S, et al. Diffusion tension imaging of prostate at 3.0 Tesla[J]. Acta Radiol, 2011, 52(7): 813-817.
[31]Park SY, Kim CK, Park BK, et al. Diffusion-tensor MRI at 3T: differentiation of central gland prostate cancer from benign prostatic hyperplasia[J]. AJR, 2014, 202(3): 254-262.
[32]巩涛，袁淑绘，李莉莉，等. 前列腺癌DTI参数与Gleason评分的相关性研究[J]. 医学影像学杂志，2014，24（4）：574-577.
[33]王锡臻，沈蓁，王滨，等. 磁共振扩散张量成像在前列腺疾病诊断中的应用[J]. 临床放射学杂志，2010，29（7）：926-928.
[34]Gürses B, Kabakci N, Kovanlikaya A, et al. Diffusion tensor imaging of the normal prostate at 3 Tesla[J]. Eur Radiol, 2008, 18(4): 716-721.
[35]Manenti G, Carlani M, Mancino S, et al. Diffusion tensor magnetic resonance imaging of prostate cancer[J]. Invest Radiol, 2007, 42(6): 412-419.
[36]Gürses B, Tasdelen N, Yencilek F, et al. Diagnostic utility of DTI in prostate cancer[J]. Eur J Radiol, 2011, 79(2): 172-176.
[37]Le Bihan D, Breton E, Lallemand D, et al. MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurogic disorders[J]. Radiology, 1986, 161(2): 401-407.
[38]Pang Y, Turkbey B, Bernardo M, et al. Intravoxel incoherent motion MR imaging for prostate cancer: an evaluation of perfusion fraction and diffusion coefficient derived from different b-value combinations[J]. Magn Reson Med, 2013, 69(2): 533-562.
[39]Mazaheri Y, Vargas HA, Akin O, et al. Reducing the influence of b-value selection on diffusion-weighted imaging of the prostate: evaluation of a revised monoexponential model within a clinical setting[J]. J Magn Reson Imaging, 2012, 35(3): 660-668.
[40]Dpfert J, Lemke A, Weidner A, et al. Investigation of prostate cancer using diffusion-weighted intravoxel incoherent motion imaging[J]. Magn Reson Imaging, 2011, 29(8): 1053-1058.
[41]Jensen JH, Helpern JA, Ramani A, et al. Diffusional kurtosis imaging: the quantification of non-Gaussian water diffusion by means of magnetic resonance imaging[J]. Magn Reson Med, 2005, 53(6): 1432-1440.
[42]Tamura C, Shinmoto H, Soga S, et al. Diffusion kurtosis imaging study of prostate cancer: preliminary findings[J]. J Magn Reson Imaging, 2014, 40(3): 723-729.
[43]Suo S, Chen X, Wu L, et al. Non-Gaussian water diffusion kurtosis imaging of prostate cancer[J]. Magn Reson Imaging, 2014, 32(5): 421-427.
[44]Sehgal V, Delproposto Z, Haddar D, et al. Susceptibility-weighted imaging to visualize blood products and improve tumor contrast in the study of brain masses[J]. J Magn Reson Imaging, 2006, 24(1): 41-51.
[45]Qi WX, Fu S, Zhang Q, et al. Efficacy and toxicity of anti-VEGF agents in patients with castration-resistant prostate cancer: a meta-analysis of prospective clinical studies[J]. Asian Pac J Cancer Prev, 2014, 15(19): 8177-8182.
[46]Yang ZS, Xu YF, Huang FF, et al. Associations of nm23H1, VEGF-C, and VEGF-3 receptor in human prostate cancer[J]. Molecules, 2014, 19(5): 6851-6862.
[47]Gumus K, Koc G, Doganay S, et al. Susceptibility-based differentiation of intracranial calcification and hemorrhage in pediatric patients[J]. J Child Neurol, 2014, 30(8): 1029-1036.
[48]Bai Y, Wang MY, Han YH, et al. Susceptibility weighted imaging: a new tool in the diagnosis of prostate cancer and detection of prostatic calcification[J]. PLoS One, 2013, 8(1): e53237.